Warar Degdeg ah
Saynis

Galmed oo la-shaqaynaysa Jaamacadda Tel Abiib si ay u tijaabiso Daawaynta Kansarka Maskaxda

Shirkadda Galmed Pharmaceuticals ayaa la kaashanaysa Jaamacadda Tel Abiib si ay u sahamiso daroogadeeda Aramchol oo loo arko inay daaweyn u noqon karto kansarka maska ee faafay.

Yeruusaalem, 15 Abriil, 2026 (TPS-IL) — Shirkadda Galmed Pharmaceuticals Ltd., oo ah shirkad Israa’iili oo horumarisa daawooyin xilliyada daraasaadka ah, ayaa ku dhawaaqday iskaashi cilmi-baaris la sameeyay Ramot, oo ah laanta wareejinta tignoolajiyada ee Jaamacadda Tel Abiib, si loo qiimeeyo daawadeeda Aramchol ee xannibta SCD1, oo ah daawo la beegsanayo kansarka maska ee faafay.

Iskaashiga wuxuu isku dari doonaa barnaamijka horumarinta daawada ee Galmed iyo natiijooyinka ka soo baxay cilmi-baarayaasha Jaamacadda Tel Abiib, kuwaas oo aqoonsaday xiriir ka dhexeeya daminta p53 iyo koritaanka burooyinka maska ee ay sababto SCD1. Daraasadda waxaa lagu isticmaali doonaa moodooyinka horumarsan ee cilmi-baarista hore ee laga sameeyay TAU si loo qiimeeyo in Aramchol ay burburin karto isbeddellada dheef-shiid kiimikaad ee u oggolaanaya unugyada kansarka inay ku faafaan oo ku noolaadaan maska.

author avatar
Pesach Benson